MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/15/2026, 11:01 AM (Berlin time), refresh in progress.

KORU Medical Systems Stock

KORU Medical Systems, Inc.

KRMDNASDAQMarkt
US$3.11
+3.7% today

Company data

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
United States
CEO
Adam Kalbermatten
Employees
73
Market cap
$143 M
IPO
05/04/1994

KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably…

KORU Medical Systems stock: price history

14/10/25-24.9 %14/10/26

1D

+3.7%

1W

+4.4%

1M

-1.0%

6M

-26.8%

YTD

-46.5%

1Y

-24.9%

2Y

+13.9%

5Y

+8.4%

10Y

+623.3%

Next earnings date

Next earnings date

11/11/2026 (in 25 days)

Volatility around earnings

~22% weaker price swings than usual

Ask the agents about KORU Medical Systems

Analyst assessment of KORU Medical Systems

PRICE TARGET LOW

US$6.00

CONSENSUS

US$6.00

MEDIAN

US$6.00

PRICE TARGET HIGH

US$6.00

0

STRONG BUY

4

BUY

1

HOLD

0

SELL

0

STRONG SELL

5

TOTAL · Buy

As of: 13/03/2026

ANALYST FIRMRATINGACTIONDATE
B. Riley SecuritiesBuymaintain13/03/2026
Canaccord GenuityBuymaintain13/03/2026
Lake StreetBuymaintain22/12/2025
Canaccord GenuityBuymaintain17/12/2025
Piper SandlerNeutralmaintain07/08/2025 (older than 12 months)
Piper SandlerNeutralmaintain08/05/2025 (older than 12 months)
Piper SandlerOverweight → Neutraldowngrade14/02/2025 (older than 12 months)
Craig-HallumBuymaintain17/01/2025 (older than 12 months)

KORU Medical Systems stock metrics

P/E

-79.34

P/B

7.94

EV/EBITDA

-135.38

RETURN ON EQUITY

1.4%

NET MARGIN

2.1%

DEBT/EQUITY

0.18

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

93.7%

FLOAT SHARES

43,049,664

AVG. DAILY VOLUME (30D)

260,219

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

French Donna

DirectorGrant5,1192.93Spontaneous01/10/2026

FLETCHER R JOHN

DirectorGrant7,6792.93Spontaneous01/10/2026

CASCELLA ROBERT

DirectorGrant5,1192.93Spontaneous01/10/2026

Manko Joseph M. Jr.

10% ownerGrant5,119–Spontaneous01/10/2026

WHOLIHAN EDWARD

DirectorGrant5,1192.93Spontaneous01/10/2026
Page 1 / 6

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
First Light Asset Management, LLC3,387,902-380,47830/06/2026
Topline Capital Management, LLC3,373,842-141,06930/06/2026
BlackRock, Inc.2,628,352+256,52630/06/2026
VANGUARD CAPITAL MANAGEMENT LLC1,818,121+131,89730/06/2026
GEODE CAPITAL MANAGEMENT, LLC1,128,096+76,88830/06/2026
Page 1 / 3

Comparable stocks

Frequently asked questions about KORU Medical Systems stock

What does KORU Medical Systems do?

KORU Medical Systems, Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.

The CEO is Adam Kalbermatten, the company employs around 73 people.

The IPO was on 05/04/1994; the stock trades on NASDAQ under the ticker KRMD.

What do analysts say about KORU Medical Systems stock?

5 analysts rate the stock, the consensus is Buy (as of 13/03/2026).

The average price target is US$6.00, ranging from US$6.00 to US$6.00, with a median of US$6.00.

This is an external assessment, not a statement by Market Jury.

When does KORU Medical Systems report next?

The next earnings date is 11/11/2026.

Around past earnings, price swings were roughly -22% stronger than usual.

Does KORU Medical Systems pay a dividend?

No, KORU Medical Systems currently does not pay a dividend.

Which stocks are comparable to KORU Medical Systems?

Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.

How can I get KORU Medical Systems stock analyzed?

Clicking "Analyze stock" lets five strategies assess KORU Medical Systems against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.